Where is entyvio manufactured?

Where is Entyvio manufactured?

Entyvio (vedolizumab) is an injectable medication used to treat certain gastrointestinal diseases, including ulcerative colitis and Crohn's disease. The medication is manufactured by Takeda Pharmaceuticals, a Japanese multinational pharmaceutical company [1].

Who distributes Entyvio worldwide?

Although Takeda distributes Entyvio in various countries worldwide, not all regions are supplied directly by the company. In some areas, other pharmaceutical companies act as distributors for Entyvio under licensing agreements. For instance, in the United States, AbbVie distributes Entyvio.

What are the manufacturing facilities for Entyvio?

Takeda's manufacturing facility located in Osaka, Japan produces Entyvio [1]. The company also has a network of other manufacturing sites around the world, but Entyvio is primarily manufactured in Japan. As with many pharmaceuticals, the global distribution network involves complex supply chains, and Entyvio may be filled and packaged by contract manufacturers in other regions.

Is Entyvio approved in multiple regions?

Yes, Entyvio has regulatory approval in several countries, including the United States, the European Union, Canada, and Japan. Takeda's manufacturing facilities are subject to strict regulatory oversight to ensure compliance with international quality and safety standards [2].

When did Entyvio receive approval?

Entyvio was initially approved by the U.S. Food and Drug Administration (FDA) in 2014 [3].

References:

[1] DrugPatentWatch.com. (n.d.). Vedolizumab - drug patent information. Retrieved from https://www.drugpatentwatch.com/drug/1550-vedolizumab

[2] FDA. (2014). FDA Approves Entyvio for the Treatment of Ulcerative Colitis and Crohn's Disease.

[3] FDA. (2014). FDA Approval Letter - Vedolizumab (Vedolizumab) For Intravenous Use

Sources:

1. DrugPatentWatch.com
2. FDA
3. FDA